Cargando…

The Evaluation of Clot Waveform Analyses for Assessing Hypercoagulability in Patients Treated with Factor VIII Concentrate

Background: Regular prophylactic therapy has become an increasingly common treatment for severe hemophilia. Therefore, hypercoagulability—a potential risk factor of thrombosis—is a cause for concern in hemophilic patients treated with a high dose of FVIII concentrate. In clot waveform analysis (CWA)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsumoto, Takeshi, Wada, Hideo, Shiraki, Katsuya, Suzuki, Kei, Yamashita, Yoshiki, Tawara, Isao, Shimpo, Hideto, Shimaoka, Motomu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573981/ https://www.ncbi.nlm.nih.gov/pubmed/37834964 http://dx.doi.org/10.3390/jcm12196320

Ejemplares similares

A Clot Waveform Analysis of Thrombin Time Using a Small Amount of Thrombin Is Useful for Evaluating the Clotting Activity of Plasma Independent of the Presence of Emicizumab
por: Wada, Hideo, et al.
Publicado: (2022)

Clot Waveform Analysis for Hemostatic Abnormalities
por: Wada, Hideo, et al.
Publicado: (2023)

Clot Waveform Analysis Demonstrates Low Blood Coagulation Ability in Patients with Idiopathic Thrombocytopenic Purpura
por: Wada, Hideo, et al.
Publicado: (2021)

The Reevaluation of Thrombin Time Using a Clot Waveform Analysis
por: Wada, Hideo, et al.
Publicado: (2021)

A Clot Waveform Analysis Showing a Hypercoagulable State in Patients with Malignant Neoplasms
por: Kobayashi, Mayu, et al.
Publicado: (2021)

The Detection of Hypercoagulability in Patients with Acute Cerebral Infarction Using a Clot Waveform Analysis
por: Kamon, Toshitaka, et al.
Publicado: (2023)

Update on the Clot Waveform Analysis
por: Wada, Hideo, et al.
Publicado: (2020)

Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019
por: Wada, Hideo, et al.
Publicado: (2023)

The Evaluation of APTT Reagents in Reference Plasma, Recombinant FVIII Products; Kovaltry® and Jivi® Using CWA, Including sTF/7FIX Assay
por: Wada, Hideo, et al.
Publicado: (2021)

Plasma Soluble Fibrin Is Useful for the Diagnosis of Thrombotic Diseases
por: Ezaki, Minoru, et al.
Publicado: (2023)

Soluble C-Type Lectin-Like Receptor 2 Is a Biomarker for Disseminated Intravascular Coagulation
por: Yamamoto, Akitaka, et al.
Publicado: (2021)

Elevated D-Dimer Levels Predict a Poor Outcome in Critically Ill Patients
por: Ichkawa, Yuhuko, et al.
Publicado: (2020)

D-dimer kit with a High FDP/D-Dimer Ratio is Useful for Diagnosing Thrombotic Diseases
por: Ikeda, Nozomi, et al.
Publicado: (2022)

Proposal of Quick Diagnostic Criteria for Disseminated Intravascular Coagulation
por: Wada, Hideo, et al.
Publicado: (2022)

Elevated Plasma Soluble C-Type Lectin-like Receptor 2 Is Associated with the Worsening of Coronavirus Disease 2019
por: Wada, Hideo, et al.
Publicado: (2022)

Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2
por: Yamamoto, Akitaka, et al.
Publicado: (2023)

Comments to: An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia by APTT Waveform, Peak Heights of APTT Waveform Are Useful for Diagnosing Hemophilia or Inhibitor
por: Matsumoto, Takeshi, et al.
Publicado: (2019)

Soluble C-Type Lectin-Like Receptor 2 Elevation in Patients with Acute Cerebral Infarction
por: Nishigaki, Akisato, et al.
Publicado: (2021)

Hypercoagulation in COPD: the clot thickens
por: Rahaghi, Farbod N., et al.
Publicado: (2021)

Usefulness of the APTT waveform for the diagnosis of DIC and prediction of the outcome or bleeding risk
por: Suzuki, Kei, et al.
Publicado: (2019)

The Evaluation of Hemostatic Abnormalities Using a CWA-Small Amount Tissue Factor Induced FIX Activation Assay in Major Orthopedic Surgery Patients
por: Hasegawa, Masahiro, et al.
Publicado: (2021)

COVID-19 associated coagulopathy in critically ill patients: A hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis
por: Fan, Bingwen Eugene, et al.
Publicado: (2020)

Biomarkers of Hypercoagulability in COVID-19
por: Wada, Hideo
Publicado: (2023)

An Evaluation of Hemostatic Abnormalities in Patients With Hemophilia According to the Activated Partial Thromboplastin Time Waveform
por: Katayama, Haruna, et al.
Publicado: (2018)

Life-Threatening Tongue and Retropharyngeal Hemorrhage in a Patient with Hemophilia A with Inhibitors
por: Kageyama, Yuki, et al.
Publicado: (2019)

Evaluation of Biomarkers of Severity in Patients with COVID-19 Infection
por: Yamamoto, Akitaka, et al.
Publicado: (2021)

Blood Clotting Factor VIII: From Evolution to Therapy
por: Orlova, N. A., et al.
Publicado: (2013)

Monitoring of different factor VIII replacement products using a factor VIII one‐stage clotting assay on cobas t 511/711 analysers
por: Ketteler, Carolin, et al.
Publicado: (2021)

Hypercoagulability in COVID-19: A review of the potential mechanisms underlying clotting disorders
por: Alam, Walid
Publicado: (2021)

Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines
por: Wada, Hideo, et al.
Publicado: (2014)

Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation
por: Randeria, Shehan N., et al.
Publicado: (2019)

Paroxysmal atrial fibrillation: changes in factor VIII and von Willebrand factor impose early hypercoagulability
por: Negreva, Mariya Negrinova, et al.
Publicado: (2020)

Utility of Clot Waveform Analysis in Russell's Viper Bite Victims with Hematotoxicity
por: Abraham, Siju V., et al.
Publicado: (2018)

Clot waveform of APTT has abnormal patterns in subjects with COVID-19
por: Shimura, Takuya, et al.
Publicado: (2021)

Development and validation of a novel qualitative test for plasma fibrinogen utilizing clot waveform analysis
por: Suzuki, Atsuo, et al.
Publicado: (2022)

Is early treatment of disseminated intravascular coagulation beneficial in septic patients?
por: Wada, Hideo, et al.
Publicado: (2014)

Clot stability as a determinant of effective factor VIII replacement in hemophilia A
por: Leong, Lilley, et al.
Publicado: (2017)

Efanesoctocog alfa elicits functional clot formation that is indistinguishable to that of recombinant factor VIII
por: Demers, Melanie, et al.
Publicado: (2022)

THE CLOT THICKENS: DOES THE JOHNSON & JOHNSON COVID-19 VACCINE INCREASE THE RISK OF THROMBUS IN A HYPERCOAGULABLE STATE?
por: RUTENBERG, DAVID, et al.
Publicado: (2021)

Neutrophil-to-lymphocyte ratio, Factor VIII and Antithrombin III: inflammatory-clotting biomarkers in glioma
por: Koudriavtseva, Tatiana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_icviocgsfjendgtq3mvu81rma8